Drug compliance among hypertensive patients in Tabuk, Saudi Arabia.
about
Safety and tolerability of fixed antihypertensive combinations in blood pressure control: focus on olmesartan medoxomil and amlodipine combinationManagement of blood pressure in patients with type 2 diabetes mellitus: a nationwide survey in korean.A systematic review of adherence to cardiovascular medications in resource-limited settings.Quality of life in a sample of hypertensive patients attending primary health care facilities in Al-khobar, saudi arabiaDoctor-patient communication: a skill needed in saudi arabia.Medication adherence among hypertensive patients of primary health clinics in Malaysia.Predictors of Medication Adherence and Blood Pressure Control among Saudi Hypertensive Patients Attending Primary Care Clinics: A Cross-Sectional Study.Fixed combinations in the management of hypertension: patient perspectives and rationale for development and utility of the olmesartan-amlodipine combinationDrug compliance among hypertensive patients in a teaching hospital.Adherence to Long-Term Therapies and Beliefs about MedicationsFrequency, types and severity of medication use-related problems among medical outpatients in Nigeria.Compliance to Hypertension Treatment in Residents of a Fishermen Colony in District Kollam, Kerala.Hypertension control and co-morbidities in primary health care centers in Riyadh.Adherence to treatment and evaluation of disease and therapy knowledge in Lebanese hypertensive patients.Factors related to medication non-adherence for patients with hypertension in Taiwan.Factors associated with uncontrolled blood pressure among Ghanaians: Evidence from a multicenter hospital-based study.
P2860
Q35210547-B800692D-8D94-4857-98F9-D7C53C398341Q35228187-49A4A7D8-565C-4A13-8446-D7E1E53DFFD8Q35606853-093D3961-8C1C-4766-B1E5-6C9852B5CF8EQ36197024-044BC991-BD58-479C-8545-003D45935616Q36197039-0CDD972E-B1A4-4C01-8A28-03E724EE8BDBQ36222020-2C35BED3-E3FF-47DA-9491-959AE08207CBQ36263938-905B3E99-1ED6-4F11-B5AE-08488A3E147DQ36835866-547CA710-4FBD-4CCD-BF7E-CD2331F6A15EQ37300153-FDA88F42-2673-4587-B263-5C714399046CQ37618699-CDBE92D5-434E-4858-9BDC-687657E3B828Q37869834-DAC7E7F0-6E1E-43F9-A267-2CDFDDF64841Q39970357-890153AA-D9F4-43C4-BEFF-82355C2171B1Q43741843-AD6B41B3-9240-413F-BF40-2F5858151C77Q47151274-67ED2AB8-293F-4D83-A496-2781C2222CA6Q47658299-E04D2E15-2474-452C-A048-5D9D899FC0C2Q54957956-7BA44345-6AA4-4188-8E93-A2FA7878C0B0
P2860
Drug compliance among hypertensive patients in Tabuk, Saudi Arabia.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年学术文章
@wuu
1997年学术文章
@zh
1997年学术文章
@zh-cn
1997年学术文章
@zh-hans
1997年学术文章
@zh-my
1997年学术文章
@zh-sg
1997年學術文章
@yue
1997年學術文章
@zh-hant
name
Drug compliance among hypertensive patients in Tabuk, Saudi Arabia.
@en
Drug compliance among hypertensive patients in Tabuk, Saudi Arabia.
@nl
type
label
Drug compliance among hypertensive patients in Tabuk, Saudi Arabia.
@en
Drug compliance among hypertensive patients in Tabuk, Saudi Arabia.
@nl
prefLabel
Drug compliance among hypertensive patients in Tabuk, Saudi Arabia.
@en
Drug compliance among hypertensive patients in Tabuk, Saudi Arabia.
@nl
P1476
Drug compliance among hypertensive patients in Tabuk, Saudi Arabia.
@en
P2093
Elzubier AG
P304
P356
10.1097/00004872-199715050-00013
P577
1997-05-01T00:00:00Z